FDA Takes Steps Aimed at Fostering Development of Non-Addictive Alternatives to Opioids
Today, the U.S. Food and Drug Administration (FDA) took new steps aimed at fostering the development of non-addictive alternatives to opioids to manage acute...
Health Systems Can Apply for Funding to Improve Patient Outcomes
On Feb. 15, the Patient-Centered Outcomes Research Institute (PCORI) will launch an AHA-informed initiative that will provide funding to help health care delivery systems...
FDA Issues Update on Ventilator Recall
The Food and Drug Administration (FDA) last week issued an update on the Class 1 recall of certain Philips Respironics ventilators. According to the update,...
Cyber Security Advisory for the U.S. Healthcare Industry
​On February 1, 2022, the American Hospital Association released a Cyber Security Advisory warning of the increased cyber risk to U.S. Health Care due...
New Materials Available for Healthcare Professionals Supporting Pregnant and Postpartum Patients
CDC released a new webpage and suite of materials for healthcare professionals as part of the Hear Her campaign, which aims to reduce pregnancy-related deaths. Over...
CDC: Unvaccinated Adults 3-5 Times More Likely to get Omicron Infection
According to data from 25 state and local health departments, adults who were unvaccinated against COVID-19 as the omicron variant emerged in December had...
FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron...
In light of the most recent information and data available, on January 24 the FDA revised the authorizations for two monoclonal antibody treatments –...
AHA Urges HRSA to Delay Withdrawal of Health Professional Shortage Areas
​The American Hospital Association (AHA) asked the Health Resources and Services Administration to delay by at least one year the effective withdrawal date for...
$103 Million in American Rescue Plan Funds to Reduce Burnout and Promote Mental Health...
The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), today announced $103 million in awards to...
FDA authorizes Remdesivir for Certain Non-Hospitalized Patients, New At-Home Test for COVID-19
The Food and Drug Administration Friday expanded the approved uses for Vekury (remdesivir) to include non-hospitalized patients aged 12 and older who test positive for SARS-CoV-2,...
